김재성 (한국원자력의학원)님 | 한빛사연구자 > 한빛사

한국원자력의학원

최종업데이트 2022.09.29.

Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract
- Eur. J. Cancer, Volume 173, September 2022, Pages 41-51 | https://doi.org/10.1016/j.ejca.2022.06.031
- 2022-09
- 의약학
- 한빛사논문
PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation
- J. Immunother. Cancer, Online issue publication March 14, 2022 | http://dx.doi.org/10.1136/jitc-2021-003762
- 2022-03
- 의약학
- 한빛사논문
Melatonin protects mouse oocytes from DNA damage by enhancing non‐homologous end‐joining repair
- J. Pineal Res., First published: 01 August 2019 | https://doi.org/10.1111/jpi.12603
- 2019-08
- 생명과학
- 한빛사논문

연구자 ID

저자논문